Wesana Health(OTC) WSNAF

Market Cap$73.20K

Since IPO (2021)-100%

5 Year-100%

1 Year-74%

1 Month+0%

$0.00

+0.00%

+0.00Today

Wesana Health last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-28

Wesana Health stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-03
1 month	+0%	USD 0.00	2026-07-14
3 month	+0%	USD 0.00	2026-04-21
Year to date	-65%	USD 0.01	2025-12-31
1 year	-74.07%	USD 0.01	2025-08-28
3 year	-91.75%	USD 0.04	2023-08-29
5 year	-99.86%	USD 2.48	2021-08-27
Since inception	-99.89%	USD 3.10	2021-05-10

Wesana Health Financials at a Glance

Market Cap

$73.20K

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.18M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-742.96 (Low)

Dividend

$0.00

Beta (Volatility)

-742.96 (Low)

Price

$0.00

Volume

200

Open

$0.00

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

Aug 28, 2026

Dividend

$0.00

Beta (Volatility)

-742.96 (Low)

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

Aug 28, 2026

WSNAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wesana Health

Wesana Health Holdings Inc. is a life sciences firm focused on advancing psychedelic-based therapies, particularly psilocybin-enhanced psychotherapy. The company aims to address traumatic brain injuries (TBI) and related mental health conditions through scientifically validated compounds and therapeutic strategies.

Products and Services

Psychedelic-based therapies targeting TBI and mental health
Psilocybin-enhanced psychotherapy for trauma recovery
Research and development of innovative therapeutic strategies

Growth Outlook

Potential market growth in psychedelic therapies is significant
Increasing acceptance of mental health treatments using psychedelics
Focus on scientific validation may attract partnerships and funding

Financial Highlights

Recent quarterly net income of -$36,666 with a focus on reducing operating expenses
Trailing twelve months (TTM) revenue remains at $0, indicating early-stage development
Cash and short-term investments totaled $46,929 as of September 30, 2024

Wesana Health Holdings Inc. operates in the burgeoning field of psychedelic therapy, which is gaining traction as a viable treatment option for various mental health issues. The company's commitment to scientific validation positions it favorably within the industry, potentially leading to strategic partnerships and funding opportunities. Despite current financial challenges, including a net income loss and zero revenue, the focus on innovative therapeutic strategies may pave the way for future growth. The market for psychedelic therapies is expanding, and Wesana Health is poised to capitalize on this trend as acceptance of such treatments increases.

AI Generated • Aug 23, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Daniel Carcillo

Website

www.wesanahealth.com

Headquarters

Chicago, IL 60607, US

WSNAF Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-506.80%

Return on Capital

N/A

Return on Assets

-176.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$73.20K

Shares Outstanding

20.92M

Volume

200

Avg. Volume

37.578

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$460.16K

EBITDA

-$567.22K

Operating Cash Flow

-$422.96K

Capital Expenditure

$1.00

Free Cash Flow

-$422.95K

Cash & ST Invst.

$46.93K

Total Debt

$250.00K

Wesana Health Performance Analysis

Wesana Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 0	N/A
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A

Wesana Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	N/A
Q1	2024-03-31	N/A
Q2	2024-06-30	N/A
Q3	2024-09-30	N/A

Wesana Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -1.48	N/A
2022	2022-12-31	USD -0.25	-83.1%
2023	2023-12-31	USD -0.05	-80.3%

Wesana Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	-300.0%
Q1	2024-03-31	82.8%
Q2	2024-06-30	8.2%
Q3	2024-09-30	82.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$73.20K

N/A

Market Cap/Employee

$10.46K

N/A

Employees

N/A

Net Income

-$36.67K

-105.9%

EBITDA

-$33.06K

+96.4%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Total Cash

$46.93K

-93.1%

Total Debt

$250.00K

+0.0%

Accounts Receivable

$50.92K

-94.6%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$250.00K

+0.0%

Return on Assets

-1.77%

N/A

Return on Invested Capital

4.13%

N/A

Free Cash Flow

-$16.68K

+93.2%

Operating Cash Flow

-$16.68K

+93.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LFCOFLift & Co. Corp.

LFCOFLift & Co. Corp.$0.00+0.00%

NBIONascent Biotech, Inc.

NBIONascent Biotech, Inc.$0.00+0.00%

RGBPRegen BioPharma, Inc.

RGBPRegen BioPharma, Inc.$0.00+0.00%

RGRXRegeneRx Biopharmaceuticals, Inc.

RGRXRegeneRx Biopharmaceuticals, Inc.$0.00+0.00%

IPIXInnovation Pharmaceuticals Inc.

IPIXInnovation Pharmaceuticals Inc.$0.00-85.00%

GRVEGroove Botanicals, Inc.

GRVEGroove Botanicals, Inc.$0.00+0.00%

RASPActavia Life Sciences, Inc.

RASPActavia Life Sciences, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.15-0.12%

NVDANvidia

NVDANvidia$230.36+0.01%

PATHUiPath

PATHUiPath$15.19-0.17%

INTCIntel

INTCIntel$95.80+0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.13+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.74-0.02%

TSLATesla

TSLATesla$354.08-0.06%

Questions About WSNAF

What is the current price of Wesana Health?

Wesana Health is trading at $0.00 per share.

What is the 52-week range for Wesana Health?

Over the past 52 weeks, Wesana Health has traded between $0.00 and $0.04.

How much debt does Wesana Health have?

As of the most recent reporting period, Wesana Health reported total debt of $250.00K.

How much cash does Wesana Health have on hand?

Wesana Health reported $44.30K in cash and cash equivalents in its most recent financial results.

What is Wesana Health’s dividend yield?

Wesana Health does not currently have a dividend yield.

Wesana Health(OTC) WSNAF

Wesana Health Financials at a Glance

WSNAF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Wesana Health

WSNAF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Wesana Health Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WSNAF

What is the current price of Wesana Health?

What is the 52-week range for Wesana Health?

How much debt does Wesana Health have?

How much cash does Wesana Health have on hand?

What is Wesana Health’s dividend yield?

Premium Investing Services